Changes in neural circuitry regulating response-reversal learning and arc-mediated consolidation of learning in rats with methamphetamine-induced partial monoamine loss

Neuropsychopharmacology

Volumn 39, Issue 4, 2014, Pages 963-972

  Pastuzyn, Elissa D ^a   Keefe, Kristen A ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Arc; memory consolidation; methamphetamine; nucleus accumbens; reversal learning; striatum

Indexed keywords

ANIMALS; BIOGENIC MONOAMINES; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CYTOSKELETAL PROTEINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION REGULATION; MALE; METHAMPHETAMINE; NERVE NET; NERVE TISSUE PROTEINS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RETENTION (PSYCHOLOGY); REVERSAL LEARNING; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84894065766     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.296     Document Type: Article

References (49)

1. Barker-Haliski ML, Oldenburger K, Keefe KA (2012a). Disruption of subcellular Arc/Arg 3.1 mRNA expression in striatal efferent neurons following partial monoamine loss induced by methamphetamine. J Neurochem 123: 845-855.
2. Barker-Haliski ML, Pastuzyn ED, Keefe KA (2012b). Expression of the core exon-junction complex factor eukaryotic initiation factor 4A3 is increased during spatial exploration and striatally mediated learning. Neuroscience 226: 51-61.
3. Beauchamp MH, Dagher A, Panisset M, Doyon J (2008). Neural substrates of cognitive skill learning in Parkinson's disease. Brain Cogn 68: 134-143.
4. Boja JW, Mitchell WM, Patel A, Kopajtic TA, Carroll FI, Lewin AH et al (1992). High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12: 27-36.
5. Calabresi P, Picconi B, Tozzi A, Di Filippo M (2007). Dopaminemediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 30: 211-219.
6. Callaghan RC, Cunningham JK, Sykes J, Kish SJ (2012). Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend 120: 35-40.
7. Chapman DE, Hanson GR, Kesner RP, Keefe KA (2001). Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine. J Pharmacol Exp Ther 296: 520-527.
8. Czerniawski J, Ree F, Chia C, Ramamoorthi K, Kumata Y, Otto TA (2011). The importance of having Arc: expression of the immediate-early gene Arc is required for hippocampus-dependent fear conditioning and blocked by NMDA receptor antagonism. J Neurosci 31: 11200-11207.
9. Daberkow DP, Kesner RP, Keefe KA (2005). Relation between methamphetamine-induced monoamine depletions in the striatum and sequential motor learning. Pharmacol Biochem Behav 81: 198-204.
10. Daberkow DP, Riedy MD, Kesner RP, Keefe KA (2007). Arc mRNA induction in striatal efferent neurons associated with response learning. Eur J Neurosci 26: 228-241.
11. Daberkow DP, Riedy MD, Kesner RP, Keefe KA (2008). Effect of methamphetamine neurotoxicity on learning-induced Arc mRNA expression in identified striatal efferent neurons. Neurotox Res 14: 307-315.
12. Dean AC, Groman SM, Morales AM, London ED (2013). An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology 38: 259-274.
13. Ganguly A, Keefe KA (2001). Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-Daspartate receptor in enkephalin-positive and enkephalinnegative neurons. Neuroscience 103: 405-412.
14. Groenewegen HJ, Wright CI, Beijer AVJ, Voorn P (1999). Convergence and segregationg of ventral striatal inputs and outputs. Ann N Y Acad Sci 877: 49-63.
15. Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF et al (2000). Inhibition of activity-dependent Arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of longterm memory. J Neurosci 20: 3993-4001.
16. Guzowski JF, Setlow B, Wagner EK, McGaugh JL (2001). Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268. J Neurosci 21: 5089-5098.
17. Haughey HM, Fleckenstein AE, Hanson GR (1999). Differential regional effects of methampetamine on the activities of tryptophan and tyrosine hydroxylase. J Neurochem 72: 661-668.
18. Hearing MC, Schwendt M, McGinty JF (2011). Suppression of activity-regulated cytoskeleton-associated gene expression in the dorsal striatum attenuates extinction of cocaine-seeking. Int J Neuropsychopharmacol 14: 784-795.
19. Hearing MC, See RE, McGinty JF (2008). Relapse to cocaineseeking increases activity-regulated gene expression differentially in the striatum and cerebral cortex of rats following short or long periods of abstinence. Brain Struc Funct 213: 215-227.
20. Holloway CM, McIntyre CK (2011). Post-training disruption of Arc protein expression in the anterior cingulate cortex impairs longterm memory for inhibitory avoidance training. Neurobiol Learn Mem 95: 425-432.
21. Howard CD, Daberkow DP, Ramsson ES, Keefe KA, Garris PA (2013a). Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling. Eur J Neurosci 38: 2078-2088.
22. Howard CD, Keefe KA, Garris PA, Daberkow DP (2011). Methamphetamine- induced neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum. J Neurochem 118: 668-676.
23. Howard CD, Pastuzyn ED, Barker-Haliski ML, Garris PA, Keefe KA (2013b). Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamineinduced partial dopamine denervation. J Neurochem125: 555-565.
24. Humphries MD, Prescott TJ (2010). The ventral basal ganglia, a selection mechanism at the crossroads of space, strategy, and reward. Prog Neurobiol 90: 385-417.
25. Ikemoto S (2007). Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbensolfactory tubercle complex. Brain Res Rev 56: 27-78.
26. Johnson-Davis KL, Hanson GR, Keefe KA (2002). Long-term postsynaptic consequences of methamphetamine on preprotachykinin mRNA expression. J Neurochem 82: 1472-1479.
27. Lv X-F, Xu Y, Han J-S, Cui C-L (2011). Expression of activityregulated cytoskeleton-associated protein (Arc/Arg3.1) in the nucleus accumbens is critical for the acquisition, expression and reinstatement of morphine-induced conditioned place preference. Behav Brain Res 223: 182-191.
28. Lyford GL, Yamagato K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG et al (1995). Arc, a growth factor and activityregulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14: 433-445.
29. Maddox SA, Schafe GE (2011). The activity-regulated cytoskeletalassociated protein (Arc/Arg3.1) is required for reconsolidation of a Pavlovian fear memory. J Neurosci 31: 7073-7082.
30. Marshall JF, O'Dell SJ (2012). Methamphetamine influences on brain and behavior: unsafe at any speed? Trends Neurosci 35: 536-545.
31. Moody TD, Bookheimer SY, Vanek Z, Knowlton BJ (2004). An implicit learning task activates medial temporal lobe in patients with Parkinson's disease. Behav Neurosci 118: 438-442.
32. Palencia CA, Ragozzino ME (2004). The influence of NMDA receptors in the dorsomedial striatum on response reversal learning. Neurobiol Learn Mem 82: 81-89.
33. Pastuzyn ED, Chapman DE, Wilcox KS, Keefe KA (2012). Altered learning and Arc-regulated consolidation of learning in striatum by methamphetamine-induced neurotoxicity. Neuropsychopharmacology 37: 885-895.
34. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press: Orlando, FL, USA.
35. Ploski JE, Pierre VJ, Smucny J, Park K, Monsey MS, Overeem KA et al (2008). The activity-regulated cytoskeletal-associated protein (Arc/Arg3.1) is required for memory consolidation of Pavlovian fear conditioning in the lateral amygdala. J Neurosci 28: 12383-12395.
36. Ragozzino ME (2007). The contribution of the medial prefrontal cortex, orbitofrontal cortex, and dorsomedial striatum to behavioral flexibility. Ann NY Acad Sci 1121: 355-375.
37. Reynolds SM, Berridge KC (2001). Fear and feeding in the nucleus accumbens shell: rostrocaudal segregation of GABA-elicited defensive behavior versus eating behavior. J Neurosci 21: 3261-3270.
38. Ricaurte GA, Schuster CR, Seiden LS (1980). Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res 193: 153-163.
39. Rieckmann A, Fischer H, Backman L (2010). Activation in striatum and medial temporal lobe during sequence learning in younger and older adults: relations to performance. NeuroImage 50: 1303-1312.
40. SAMHAS (2011). National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration In: Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-44, HHS Publication No. (SMA) 12-4713. Substance Abuse and Mental Health Services Administration, 2012, Rockville, MD.
41. Schultz W (2007). Behavioral dopamine signals. Trends Neurosci 30: 203-210.
42. Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M et al (2006). Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 63: 90-100.
43. Shepherd JD, Bear MF (2011). New views of Arc, a master regulator of synaptic plasticity. Nat Neurosci 14: 279-284.
44. Son J-H, Kuhn J, Keefe KA (2013). Perseverative behavior in rats with methamphetamine-induced neurotoxicity. Neuropharmacology 67: 95-103.
45. Son J-H, Latimer C, Keefe KA (2011). Impaired formation of stimulus-response, but not action-outcome, associations in rats with methamphetamine-induced neurotoxicity. Neuropsychopharmacology 36: 2441-2451.
46. Usuda I, Tanaka K, Chiba T (1998). Efferent projections of the nucleus accumbens in the rat with special reference to subdivision of the nucleus: biotinylated dextran amine study. Brain Res 797: 73-93.
47. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J (1980). Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181: 151-160.
48. Wallace TL, Gudelsky GA, Vorhees CV (1999). Methamphetamineinduced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat. J Neurosci 19: 9141-9148.
49. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM et al (1996). Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Med 2: 699-703.